Oral 11ß-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial (2022)
Attributed to:
Maximising patient benefit: Leeds’ Interdisciplinary approach to translation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1530/eje-21-1197
Publication URI: http://dx.doi.org/10.1530/eje-21-1197
Type: Journal Article/Review
Parent Publication: European Journal of Endocrinology
Issue: 4